Unknown

Dataset Information

0

Gene expression profiles predict emergence of psychiatric adverse events in HIV/HCV-coinfected patients on interferon-based HCV therapy.


ABSTRACT: BACKGROUND:The efficacy of pegylated interferon-? and ribavirin (pegIFN/RBV) in the treatment of Hepatitis C infection is limited by psychiatric adverse effects (IFN-PE). Our study examined the ability of differential gene expression patterns before therapy to predict emergent IFN-PE among 28 HIV/HCV-coinfected patients treated with pegIFN-?2b/RBV. METHODS:Patients dually infected with HIV and HCV were evaluated at baseline and during treatment by board-certified psychiatrists who classified patients into 2 groups: those who developed IFN-PE and those who did not (IFN-NPE). Gene expression analysis (Affymetrix HG-U133A) was performed using peripheral blood mononuclear cells before and after initiation of treatment. Analysis of Variance, post hoc analysis based on pair-wise comparisons, and functional annotation analysis identified differentially expressed genes within and between groups. Prediction analysis for microarrays was used to test the predictive ability of selected genes. RESULTS:Twenty-four genes (16 upregulated and 8 downregulated) that were differentially expressed at baseline in patients who subsequently developed IFN-PE compared with the IFN-NPE group showed the ability to predict IFN-PE with an accuracy of 82%. In 16 patients with IFN-PE, 135 genes (117 upregulated; 18 downregulated) were significantly modulated after treatment. Of these, 10 genes have already been shown to be associated with neuropsychiatric illnesses and were significantly modulated only in patients who experienced IFN-PE. CONCLUSIONS:We describe a novel molecular diagnostic biomarker panel to predict emergent IFN-PE in HIV/HCV-coinfected patients undergoing pegIFN/RBV treatment, which may improve the identification of patients at greatest risk for IFN-PE and suggest candidate therapeutic targets for preventing or treating IFN-PE.

SUBMITTER: Rasimas J 

PROVIDER: S-EPMC3383605 | biostudies-literature | 2012 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

Gene expression profiles predict emergence of psychiatric adverse events in HIV/HCV-coinfected patients on interferon-based HCV therapy.

Rasimas Joseph J   Katsounas Antonios A   Raza Haniya H   Murphy Alison A AA   Yang Jun J   Lempicki Richard A RA   Osinusi Anu A   Masur Henry H   Polis Michael M   Kottilil Shyam S   Rosenstein Donald D  

Journal of acquired immune deficiency syndromes (1999) 20120701 3


<h4>Background</h4>The efficacy of pegylated interferon-α and ribavirin (pegIFN/RBV) in the treatment of Hepatitis C infection is limited by psychiatric adverse effects (IFN-PE). Our study examined the ability of differential gene expression patterns before therapy to predict emergent IFN-PE among 28 HIV/HCV-coinfected patients treated with pegIFN-α2b/RBV.<h4>Methods</h4>Patients dually infected with HIV and HCV were evaluated at baseline and during treatment by board-certified psychiatrists who  ...[more]

Similar Datasets

| S-EPMC3273458 | biostudies-literature
| S-EPMC4517877 | biostudies-literature
| S-EPMC2924472 | biostudies-literature
| S-EPMC4548465 | biostudies-literature
| S-EPMC4416933 | biostudies-literature
| S-EPMC9655798 | biostudies-literature
| S-EPMC6408225 | biostudies-literature
| S-EPMC4931749 | biostudies-literature
| S-EPMC6660654 | biostudies-literature
| S-EPMC8402834 | biostudies-literature